All countries are facing decisions about which population groups to prioritize for access to COVID-19 vaccination after the first vaccine products have been licensed, at which time supply shortages are inevitable. Our objective is to define the key target populations, their size, and priority for ...
Pneumococcal vaccines offer protection againststreptococcus pneumonia, a bacterial infection causing over 500,000 cases of pneumonia in the U.S. each year. Pneumonia is the seventh leading cause of death in the country, and hospitalizations related to the disease cost an estimated $9 billion annually...
Mystery Deaths Fuel Vaccine Anxieties; Recent Pneumonia Deaths among Soldiers Who Have Been Injected with the Anthrax and Smallpox Vaccines Are Renewing Fears That the Inoculations Are UnsafeByline: Timothy W. Maier, INSIGHT Since Persian Gulf War II began about 6,000 soldiers have...Timothy W....
Pneumonia vaccines were less commonly reported, and wide gaps identified populations, e.g., uptake in the Irish traveller community compared to non-travellers in the UK was 47.4% vs. 89.2% [43]. Additionally, the meningococcal vaccine was reported only in a few countries, and uptake varied ...